Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 788

Similar articles for PubMed (Select 18535872)

1.

A multifactorial prognostic index in multiple sclerosis. Cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease.

Mandrioli J, Sola P, Bedin R, Gambini M, Merelli E.

J Neurol. 2008 Jul;255(7):1023-31. doi: 10.1007/s00415-008-0827-5. Epub 2008 Jun 13.

PMID:
18535872
2.

Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS.

Villar LM, Masjuan J, González-Porqué P, Plaza J, Sádaba MC, Roldán E, Bootello A, Alvarez-Cermeño JC.

Neurology. 2002 Aug 27;59(4):555-9.

PMID:
12196648
3.
4.

Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.

Link H, Huang YM.

J Neuroimmunol. 2006 Nov;180(1-2):17-28. Epub 2006 Sep 1. Review.

PMID:
16945427
5.
6.

[Clinical characteristics and neurophysiologic findings in patients with multiple sclerosis without oligoclonal IgG in cerebrospinal fluid].

Mesaros S, Drulović J, Lević Z.

Srp Arh Celok Lek. 2003 Mar-Apr;131(3-4):122-6. Serbian.

PMID:
14608874
7.

A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials.

Amato MP, Ponziani G, Bartolozzi ML, Siracusa G.

J Neurol Sci. 1999 Oct 15;168(2):96-106.

PMID:
10526190
8.

Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis.

Villar LM, Masjuan J, González-Porqué P, Plaza J, Sádaba MC, Roldán E, Bootello A, Alvarez-Cermeño JC.

Ann Neurol. 2003 Feb;53(2):222-6.

PMID:
12557289
9.

Acute partial transverse myelitis: risk factors for conversion to multiple sclerosis.

Sellner J, Lüthi N, Bühler R, Gebhardt A, Findling O, Greeve I, Mattle HP.

Eur J Neurol. 2008 Apr;15(4):398-405. doi: 10.1111/j.1468-1331.2008.02088.x. Epub 2008 Feb 26. Erratum in: Eur J Neurol. 2008 May;15(5):532.

PMID:
18312402
10.
11.

Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta.

Annunziata P, Giorgio A, De Santi L, Zipoli V, Portaccio E, Amato MP, Clerici R, Scarpini E, Moscato G, Iudice A, Vacca G, Orefice G, Morra VB, Maimone D.

J Neurol Sci. 2006 May 15;244(1-2):97-102. Epub 2006 Feb 13.

PMID:
16473370
12.

[Late onset multiple sclerosis].

Delalande S, De Seze J, Ferriby D, Stojkovic T, Vermersch P.

Rev Neurol (Paris). 2002 Nov;158(11):1082-7. French.

PMID:
12451340
13.

Cerebrospinal fluid oligoclonal bands and progression of disability in multiple sclerosis.

Koch M, Heersema D, Mostert J, Teelken A, De Keyser J.

Eur J Neurol. 2007 Jul;14(7):797-800.

PMID:
17594338
14.

Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension.

Myhr KM, Riise T, Vedeler C, Nortvedt MW, Grønning R, Midgard R, Nyland HI.

Mult Scler. 2001 Feb;7(1):59-65.

PMID:
11321195
15.

Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome.

Ferraro D, Simone AM, Bedin R, Galli V, Vitetta F, Federzoni L, D'Amico R, Merelli E, Nichelli PF, Sola P.

J Neuroimmunol. 2013 Apr 15;257(1-2):76-81. doi: 10.1016/j.jneuroim.2013.01.011. Epub 2013 Feb 19.

PMID:
23434160
16.

[Influence of acute aggravations on the development of long-term handicap in relapsing remitting multiple sclerosis: a clinical study in 99 patients].

Gaillard N, Fabro-Perray P, Faillie JL, Le Bayon A, Castelnovo G, Dupeyron A, Froger J, Pelissier J, Labauge P.

Rev Neurol (Paris). 2007 Jan;163(1):72-81. French.

PMID:
17304175
17.

The prognostic significance of cerebrospinal fluid in multiple sclerosis.

Siritho S, Freedman MS.

J Neurol Sci. 2009 Apr 15;279(1-2):21-5. doi: 10.1016/j.jns.2008.12.029. Epub 2009 Jan 31.

PMID:
19181345
18.

Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?

Tintoré M, Rovira A, Río J, Tur C, Pelayo R, Nos C, Téllez N, Perkal H, Comabella M, Sastre-Garriga J, Montalban X.

Neurology. 2008 Mar 25;70(13 Pt 2):1079-83. Epub 2007 Sep 19.

PMID:
17881717
19.

Intrathecal IgM synthesis in pediatric MS is not a negative prognostic marker of disease progression: quantitative versus qualitative IgM analysis.

Stauch C, Reiber H, Rauchenzauner M, Strasak A, Pohl D, Hanefeld F, Gärtner J, Rostásy KM.

Mult Scler. 2011 Mar;17(3):327-34. doi: 10.1177/1352458510388543. Epub 2010 Dec 1.

PMID:
21123302
20.

Longitudinal disability curves for predicting the course of relapsing-remitting multiple sclerosis.

Achiron A, Barak Y, Rotstein Z.

Mult Scler. 2003 Oct;9(5):486-91.

PMID:
14582775
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk